Burstable Cannabis Team
Cannabis In-Focus
@burstable
Burstable News™ is a hosted solution designed to help businesses build an audience and enhance their AIO and SEO press release strategies by automatically providing fresh, unique, and brand-aligned business news content. It eliminates the overhead of engineering, maintenance, and content creation, offering an easy, no-developer-needed implementation that works on any website. The service focuses on boosting site authority with vertically-aligned stories that are guaranteed unique and compliant with Google's E-E-A-T guidelines to keep your site dynamic and engaging.
614 articles
Articles
Bud & Mary's Batch Brand Sponsors Live Art Demonstrations at 2025 Rooster Art Fest
Artists Joe Palec and Patrick Kane McGregor will each create new works during the show, with inspiration provided by Bud & Mary’s and Batch.
August 29, 2025Read more
Google Expands Advertising Access to Canadian Cannabis Companies Under Federal Compliance
Google has initiated testing of a new advertising program that grants Canadian cannabis businesses limited access to its advertising services, contingent upon meeting federal regulatory requirements. This development marks a significant shift in digital advertising policies toward the cannabis sector, which has historically...
August 29, 2025Read more
Sequoia National Park Rangers Clear 13-Acre Illegal Cannabis Grow Site
Park rangers in Sequoia National Park, California, have cleared an extensive illegal cannabis cultivation site covering roughly 13 acres. The grim results of illegal marijuana grows in California make a strong case in support of the calls by the marijuana industry, including firms like SNDL Inc. (NASDAQ: SNDL), to stamp out...
August 28, 2025Read more
Batch Sponsors Live Art Demonstrations at 2025 Rooster Art Fest in Denver
Artists Joe Palec and Patrick Kane McGregor will each create new works during the show, with inspiration provided by Bud & Mary’s and Batch
August 28, 2025Read more
Incannex Healthcare Advances Sleep Apnea and Anxiety Treatments with Promising Clinical Results
Incannex Healthcare Inc. reported continued clinical advancement for its IHL-42X treatment for obstructive sleep apnea during the fourth quarter of 2025, building on positive Phase 2 data and patient-reported outcomes. Both low- and high-dose formulations achieved statistically significant reductions in Apnoea-Hypopnoea Ind...
August 28, 2025Read more
DEA Advances Psilocybin Rescheduling Petition to HHS for Scientific Review
Federal Momentum Marks Transformative New Chapter for Safe, Regulated, Medical Psychedelic Therapies
August 28, 2025Read more
Federal Appeals Court Ruling Challenges Firearm Ban for Medical Cannabis Users
A U.S. federal appeals court has issued a significant ruling that challenges the long-standing prohibition against illicit drug users owning firearms when applied to individuals who legally use medical cannabis. This decision represents a potential shift in how federal laws intersect with state-legal cannabis programs and c...
August 27, 2025Read more
Strategic Partnership Forms End-to-End Growth Solution for Ketamine and TMS Clinics
An integrated path from patient discovery to booked mental health and wellness consultations, with purchasing leverage and operational efficiency built in.
August 27, 2025Read more
Trump Administration's Mixed Signals on Cannabis Policy Create Industry Uncertainty
The Trump administration's ambiguous stance on federal cannabis policy has created significant uncertainty for the marijuana industry, with mixed signals emerging regarding potential reform efforts. While President Trump has expressed support for medical marijuana and hinted at possible reclassification, the lack of clear d...
August 26, 2025Read more
CannaCard and Dispensify Partner to Transform Cannabis Payments with Integrated Kiosk Solution
CannaCard Corporation, creator of the cannabis industry's CannaCard payment platform, has announced a strategic partnership with technology solutions provider Dispensify to transform cannabis retail payments through fully legal and transparent cashless transactions. The collaboration embeds CannaCard's compliant payment sys...
August 26, 2025Read more
Cybin Receives Australian Approval for Phase 3 EMBRACE Study of Psychedelic Treatment CYB003
Cybin Inc., a clinical-stage neuropsychiatry company, has received approval in Australia to conduct the EMBRACE study, the second pivotal trial within its Phase 3 multinational program evaluating CYB003. The approval was granted through the Clinical Trial Notification scheme with clearance from multiple Ethics Committees of...
August 26, 2025Read more
Study Shows Recreational Cannabis Legalization Boosts Property Values and Tax Revenue
A recent study by Clever Offers reveals that legalizing recreational cannabis provides substantial economic advantages for states that have adopted such policies. The research establishes a clear connection between marijuana legalization and rising property values, along with generating billions of dollars in additional tax...
August 25, 2025Read more
MWG Holdings Marketing Executive to Address Cannabis Industry Budget Challenges at MJ Unpacked Conference
Nicole Hanratty, Vice President of Marketing at MWG Holdings Group, Inc., will serve as a featured panelist at this year's MJ Unpacked event, scheduled for September 3 at the Union Station Hotel in St. Louis, Missouri. Hanratty will join other cannabis industry c-suite professionals to address one of the sector's most criti...
August 25, 2025Read more
Ohio's Recreational Cannabis Legalization Faces Legislative Scrutiny as Industry Watches Closely
Ohio's voter-approved recreational cannabis legalization for adults aged 21 and above continues to face legislative challenges as lawmakers debate potential modifications to the law. The 2023 ballot measure received strong public support, but state legislators have spent months considering whether and how to alter the imple...
August 22, 2025Read more
NRx Pharmaceuticals Petitions FDA to Remove Benzethonium Chloride from Ketamine Products Citing Safety Concerns
NRx Pharmaceuticals has submitted a formal Citizen Petition to the U.S. Food and Drug Administration urging the agency to prohibit the use of benzethonium chloride in all ketamine products sold in the United States. The clinical-stage biopharmaceutical company argues that this chemical preservative presents known toxicity r...
August 22, 2025Read more
Trucking Industry Seeks Clarity on Cannabis Reclassification Impact on Driver Drug Testing
The American Trucking Associations (ATA) has formally requested that the Department of Transportation (DOT) provide clarification regarding how pending federal cannabis reclassification would impact drug testing protocols for commercial drivers. This move comes as the cannabis industry, including companies such as Cresco La...
August 21, 2025Read more
Green Monke Expands Hemp Beverage Portfolio with Two New Flavors Targeting National Growth
Green Monke, an award-winning hemp-D9 THC beverage brand, announced the launch of two new flavors—Orange Cream and Lychee—expanding its Happy Soda portfolio to six flavors. This expansion follows the sell-through success of Green Monke's original four flavors, which have secured top positions in convenience and grocery chan...
August 21, 2025Read more
MAGA Leaders Pressure Trump Against Cannabis Reform, Industry Watches Closely
MAGA leaders are actively pressuring President Donald Trump to reconsider his interest in loosening federal cannabis restrictions, warning that such policy changes could potentially damage American society. This political opposition emerges as cannabis industry entities, including major publicly traded companies like Canopy...
August 20, 2025Read more
IgniteIt Inc. Launches as Independent Platform for Cannabis Industry Growth and Connection
Led by former Benzinga executives, IgniteIt will serve as a dedicated platform for the cannabis industry to connect, grow, and build.
August 20, 2025Read more
NECANN New Jersey Cannabis Convention to Feature Expanded Industry Showcase and Competition in 2025
The NECANN New Jersey Cannabis Convention, in association with 420NJevents, will be held at the Atlantic City Convention Center on September 5-6, 2025. This year's event is expected to welcome over 5,000 industry attendees with 200 exhibitors showcasing their unique cannabis business ideas and products. The scale of partici...
August 20, 2025Read more
Incannex Healthcare's IHL-42X Shows Promising Results in Phase 2 OSA Study
Stonegate Capital Partners has updated its coverage on Incannex Healthcare Inc. (NasdaqGM:IXHL), highlighting the company's significant progress with its IHL-42X asset following very positive topline results from the Phase 2 study. Both the low and high dose groups achieved a statistically significant reduction in percentag...
August 20, 2025Read more